Skip to content
10-Q

Quarterly Report

STEMLINE THERAPEUTICS INC

0001104659-19-062655

← back to feed
Filed
Nov 12, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 12, 2019 50.13M sh
Capex Q3 2019 · Sep 30, 2019 $74.5K
Capex Q3 2019 · Sep 30, 2018 $94.26K
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$56.49M
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$53.74M
Short Term Investments Q3 2019 · Sep 30, 2019 $147.15M
Short Term Investments Q3 2019 · Dec 31, 2018 $50.66M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $27.38M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $9.44M
Stockholders Equity Q3 2019 · Sep 30, 2019 $175.43M
Stockholders Equity Q3 2019 · Jun 30, 2019 $100.79M
Stockholders Equity Q3 2019 · Dec 31, 2018 $42.2M
Stockholders Equity Q3 2019 · Sep 30, 2018 $63.54M
Stockholders Equity Q3 2019 · Jun 30, 2018 $81.36M
Stockholders Equity Q3 2019 · Dec 31, 2017 $47.07M
Current Liabilities Q3 2019 · Sep 30, 2019 $22.45M
Current Liabilities Q3 2019 · Dec 31, 2018 $21.22M
Total Liabilities Q3 2019 · Sep 30, 2019 $22.73M
Total Liabilities Q3 2019 · Dec 31, 2018 $21.29M
Current Assets Q3 2019 · Sep 30, 2019 $196.5M
Current Assets Q3 2019 · Dec 31, 2018 $63.06M
Total Assets Q3 2019 · Sep 30, 2019 $198.17M
Total Assets Q3 2019 · Dec 31, 2018 $63.49M
Sga Expense Q3 2019 · Sep 30, 2019 $15.41M
Sga Expense Q3 2019 · Sep 30, 2019 $50.37M
Sga Expense Q3 2019 · Sep 30, 2018 $9.65M
Sga Expense Q3 2019 · Sep 30, 2018 $24.21M
Rd Expense Q3 2019 · Sep 30, 2019 $12.33M
Rd Expense Q3 2019 · Sep 30, 2019 $40.18M
Rd Expense Q3 2019 · Sep 30, 2018 $11.76M
Rd Expense Q3 2019 · Sep 30, 2018 $35.65M
Net Income Q3 2019 · Sep 30, 2019 −$14.89M
Net Income Q3 2019 · Sep 30, 2019 −$59.14M
Net Income Q3 2019 · Sep 30, 2019 −$359.9M
Net Income Q3 2019 · Sep 30, 2018 −$21.04M
Net Income Q3 2019 · Sep 30, 2018 −$58.39M
Operating Income Q3 2019 · Sep 30, 2019 −$15.48M
Operating Income Q3 2019 · Sep 30, 2019 −$60.9M
Operating Income Q3 2019 · Sep 30, 2018 −$21.41M
Operating Income Q3 2019 · Sep 30, 2018 −$59.36M
Cost Of Revenue Q3 2019 · Sep 30, 2019 $1.07M
Cost Of Revenue Q3 2019 · Sep 30, 2019 $1.74M